AVITA Medical (RCEL) Net Equity Issued and Repurchased (2020 - 2021)
AVITA Medical (RCEL) posted Net Equity Issued and Repurchased of $69.1 million for Q3 2021, little changed on a QoQ basis from $69.1 million in Q1 2021.
AVITA Medical (RCEL) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
AVITA Medical's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $69.1 million for Q3 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $69.1 million in Q3 2021, while the trailing twelve-month figure through Dec 2025 was $138.2 million (changed N/A YoY) and the FY2025 annual result came in at $14.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was $69.1 million for Q3 2021 at AVITA Medical, roughly flat from $69.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $69.1 million in Q1 2021 and bottomed at $1000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 69.11 Mn |
| Sep 30, 2021 | 69.11 Mn |
| Mar 31, 2021 | 69.11 Mn |
| Mar 31, 2021 | 69.11 Mn |
| Mar 31, 2020 | 1,000.00 |
| Mar 31, 2020 | 1,000.00 |